Loading
Cofoe Medical Technology Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong
HK·Mcap HK$6.9B
1 insider bought shares over the last 90 days, the latest by ZHANG MIN, filed 29 Jul 2026.
Cofoe Medical Technology Co., Ltd. - H Shares: what insiders have been doing
Every trade that managers of Cofoe Medical Technology Co., Ltd. - H Shares disclose to HKEX is tracked on this page. Between 24 October 2025 and 24 October 2026, 4 insiders published 8 filings.
Only purchases show up on the open market, 1 purchase in all, filed by 1 insider. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 senior executive.
The last insider purchase was made public on 29 July 2026, 87 days ago. Typically, a trade is published a median of 10 days after it takes place. Until a filing is published, the market cannot know about the trade.
For context, the typical company on the same exchange (median of 750 companies) published 5 filings over the same period, against 8 filings here. Over the whole record (from 2026), the tally stands at 1 purchase and no sales.
Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleZhang Min1 buy
Fundamental score
Ranked 6,851 of 26,284 companies
63.6
score / 100
Value61
Quality66
FCF yld7.5%
Earn yld5.4%
EV/EBITDA12.3x
ROE7.9%
Gross mgn53%
Net mgn11%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$27.34
Analyst consensus
2 analysts1.50/5
HK$45.36Target HK$48.84(+79%)HK$52.32
Income statement
RevenueHK$3.4B
Gross profitHK$1.8B53% margin
EBITDAHK$625.9M18% margin
Net incomeHK$371.6M10.3% margin
Valuation
PER (trailing)13.0x
PER (forward)10.9x
P/Book1.0x
Beta0.60
Balance sheet & cash
Market capHK$6.9B
Total debtHK$826.2M
Free Cash FlowHK$517.6M
Debt / Equity16%
Profitability & ownership
ROE7.9%
ROA3.5%
% insiders37.8%
% institutions6.1%
Last declaration on 29 September 2026
Declarations8 total
8,000,000 sharesShareXHKGHKEX:DA20260928E00371
1,443,800 sharesShareXHKGHKEX:DA20260728E00371
Canonical exit: 21 Oct 2026 (T+90)
1,797,400 sharesShareXHKGHKEX:DA20260723E00440
8,000,000 sharesShareXHKGHKEX:DA20260623E00399
112,795,424 sharesShareXHKGHKEX:DA20260518E00018
248,750 sharesShareXHKGHKEX:DA20260518E00022
248,750 sharesShareXHKGHKEX:DA20260518E00016
19,383,809 sharesShareXHKGHKEX:DA20260518E00010
8 of 8 declarations
About Cofoe Medical Technology Co., Ltd. - H Shares
Cofoe Medical Technology Co., Ltd. is a company focused on the development and manufacturing of medical devices. It is listed on the H Shares market.